Global RNA-Seq Competitive Landscape Professional Research Report 2026
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global RNA-Seq market size will reach Million USD in 2026 and is projected to reach Million USD by 2033, with a CAGR of % (2026-2033). Notably, the China RNA-Seq market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
RNA sequencing is a high-throughput gene expression analysis technique that provides comprehensive and accurate detection of all RNA molecules in cells or tissues, revealing dynamic changes and regulatory mechanisms of gene expression. By deep sequencing the transcriptome, RNA sequencing can analyze not only mRNA but also non-coding RNA, alternative splicing events, and mutations, offering critical data for functional genomics, disease mechanism studies, and biomarker discovery. With high sensitivity, high throughput, and broad coverage, this technology is widely used in basic biological research, clinical diagnostics, drug development, and personalized medicine. RNA sequencing, combined with precise data analysis and bioinformatics processing, provides researchers with comprehensive molecular-level information, supporting the understanding of complex regulatory networks and the development of innovative therapeutic strategies.
The major global suppliers of RNA-Seq include Thermo Fisher Scientific, Illumina, BGI, PacBio, Genewiz, Macrogen, LabCorp, Roche, Qiagen, Eurofins, Novo Gene, Berry Genomics, LC Sciences, Canopy Biosciences, Macrogen, Hologic, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of RNA-Seq. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global RNA-Seq market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the RNA-Seq market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of RNA-Seq industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of RNA-Seq Include:
Thermo Fisher Scientific
Illumina
BGI
PacBio
Genewiz
Macrogen
LabCorp
Roche
Qiagen
Eurofins
Novo Gene
Berry Genomics
LC Sciences
Canopy Biosciences
Macrogen
Hologic
RNA-Seq Product Segment Include:
sRNA-Seq
targeted RNA-Seq
long-read RNA-Seq
RNA-Seq Product Application Include:
Research Institutes
Hospitals & Clinics
Biotechnology Company
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global RNA-Seq Industry PESTEL Analysis
Chapter 3: Global RNA-Seq Industry Porter’s Five Forces Analysis
Chapter 4: Global RNA-Seq Major Regional Market Size and Forecast Analysis
Chapter 5: Global RNA-Seq Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global RNA-Seq Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global RNA-Seq market size will reach Million USD in 2026 and is projected to reach Million USD by 2033, with a CAGR of % (2026-2033). Notably, the China RNA-Seq market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
RNA sequencing is a high-throughput gene expression analysis technique that provides comprehensive and accurate detection of all RNA molecules in cells or tissues, revealing dynamic changes and regulatory mechanisms of gene expression. By deep sequencing the transcriptome, RNA sequencing can analyze not only mRNA but also non-coding RNA, alternative splicing events, and mutations, offering critical data for functional genomics, disease mechanism studies, and biomarker discovery. With high sensitivity, high throughput, and broad coverage, this technology is widely used in basic biological research, clinical diagnostics, drug development, and personalized medicine. RNA sequencing, combined with precise data analysis and bioinformatics processing, provides researchers with comprehensive molecular-level information, supporting the understanding of complex regulatory networks and the development of innovative therapeutic strategies.
The major global suppliers of RNA-Seq include Thermo Fisher Scientific, Illumina, BGI, PacBio, Genewiz, Macrogen, LabCorp, Roche, Qiagen, Eurofins, Novo Gene, Berry Genomics, LC Sciences, Canopy Biosciences, Macrogen, Hologic, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of RNA-Seq. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global RNA-Seq market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the RNA-Seq market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of RNA-Seq industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of RNA-Seq Include:
Thermo Fisher Scientific
Illumina
BGI
PacBio
Genewiz
Macrogen
LabCorp
Roche
Qiagen
Eurofins
Novo Gene
Berry Genomics
LC Sciences
Canopy Biosciences
Macrogen
Hologic
RNA-Seq Product Segment Include:
sRNA-Seq
targeted RNA-Seq
long-read RNA-Seq
RNA-Seq Product Application Include:
Research Institutes
Hospitals & Clinics
Biotechnology Company
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global RNA-Seq Industry PESTEL Analysis
Chapter 3: Global RNA-Seq Industry Porter’s Five Forces Analysis
Chapter 4: Global RNA-Seq Major Regional Market Size and Forecast Analysis
Chapter 5: Global RNA-Seq Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa RNA-Seq Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global RNA-Seq Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 RNA-Seq Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 RNA-Seq Product by Type
- 1.2.1 sRNA-Seq
- 1.2.2 targeted RNA-Seq
- 1.2.3 long-read RNA-Seq
- 1.3 RNA-Seq Product by Application
- 1.3.1 Research Institutes
- 1.3.2 Hospitals & Clinics
- 1.3.3 Biotechnology Company
- 1.3.4 Others
- 1.4 Global RNA-Seq Market Size Analysis (2021-2033)
- 1.5 RNA-Seq Market Development Status and Trends
- 1.5.1 RNA-Seq Industry Development Status Analysis
- 1.5.2 RNA-Seq Industry Development Trends Analysis
- 2 RNA-Seq Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 RNA-Seq Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global RNA-Seq Market Analysis by Regions
- 4.1 RNA-Seq Overall Market: 2025 VS 2026 VS 2033
- 4.2 Global RNA-Seq Revenue and Forecast Analysis (2021-2033)
- 4.2.1 Global RNA-Seq Revenue and Market Share by Region (2021-2026)
- 4.2.2 Global RNA-Seq Revenue and Market Share Forecast by Region (2027-2033)
- 5 Global RNA-Seq Market Size by Type and Application
- 5.1 Global RNA-Seq Market Size by Type (2021-2033)
- 5.2 Global RNA-Seq Market Size by Application (2021-2033)
- 6 North America
- 6.1 North America RNA-Seq Market Size and Growth Rate Analysis (2021-2033)
- 6.2 North America Key Suppliers Analysis
- 6.3 North America RNA-Seq Market Size by Type
- 6.4 North America RNA-Seq Market Size by Application
- 6.5 North America RNA-Seq Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe RNA-Seq Market Size and Growth Rate Analysis (2021-2033)
- 7.2 Europe Key Suppliers Analysis
- 7.3 Europe RNA-Seq Market Size by Type
- 7.4 Europe RNA-Seq Market Size by Application
- 7.5 Europe RNA-Seq Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China RNA-Seq Market Size and Growth Rate Analysis (2021-2033)
- 8.2 China Key Suppliers Analysis
- 8.3 China RNA-Seq Market Size by Type
- 8.4 China RNA-Seq Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) RNA-Seq Market Size and Growth Rate Analysis (2021-2033)
- 9.2 APAC (excl. China) Key Suppliers Analysis
- 9.3 APAC (excl. China) RNA-Seq Market Size by Type
- 9.4 APAC (excl. China) RNA-Seq Market Size by Application
- 9.5 APAC (excl. China) RNA-Seq Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America RNA-Seq Market Size and Growth Rate Analysis (2021-2033)
- 10.2 Latin America Key Suppliers Analysis
- 10.3 Latin America RNA-Seq Market Size by Type
- 10.4 Latin America RNA-Seq Market Size by Application
- 10.5 Latin America RNA-Seq Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa RNA-Seq Market Size and Growth Rate Analysis (2021-2033)
- 11.2 Middle East & Africa Key Suppliers Analysis
- 11.3 Middle East & Africa RNA-Seq Market Size by Type
- 11.4 Middle East & Africa RNA-Seq Market Size by Application
- 11.5 Middle East & Africa RNA-Seq Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Suppliers
- 12.1 Global RNA-Seq Market Revenue by Key Suppliers (2021-2033)
- 12.2 RNA-Seq Competitive Landscape Analysis and Market Dynamic
- 12.2.1 RNA-Seq Competitive Landscape Analysis
- 12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Thermo Fisher Scientific
- 13.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Thermo Fisher Scientific RNA-Seq Product Portfolio
- 13.1.3 Thermo Fisher Scientific RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.2 Illumina
- 13.2.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Illumina RNA-Seq Product Portfolio
- 13.2.3 Illumina RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.3 BGI
- 13.3.1 BGI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 BGI RNA-Seq Product Portfolio
- 13.3.3 BGI RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.4 PacBio
- 13.4.1 PacBio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 PacBio RNA-Seq Product Portfolio
- 13.4.3 PacBio RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.5 Genewiz
- 13.5.1 Genewiz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Genewiz RNA-Seq Product Portfolio
- 13.5.3 Genewiz RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.6 Macrogen
- 13.6.1 Macrogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Macrogen RNA-Seq Product Portfolio
- 13.6.3 Macrogen RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.7 LabCorp
- 13.7.1 LabCorp Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 LabCorp RNA-Seq Product Portfolio
- 13.7.3 LabCorp RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.8 Roche
- 13.8.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Roche RNA-Seq Product Portfolio
- 13.8.3 Roche RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.9 Qiagen
- 13.9.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Qiagen RNA-Seq Product Portfolio
- 13.9.3 Qiagen RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.10 Eurofins
- 13.10.1 Eurofins Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Eurofins RNA-Seq Product Portfolio
- 13.10.3 Eurofins RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.11 Novo Gene
- 13.11.1 Novo Gene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Novo Gene RNA-Seq Product Portfolio
- 13.11.3 Novo Gene RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.12 Berry Genomics
- 13.12.1 Berry Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Berry Genomics RNA-Seq Product Portfolio
- 13.12.3 Berry Genomics RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.13 LC Sciences
- 13.13.1 LC Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 LC Sciences RNA-Seq Product Portfolio
- 13.13.3 LC Sciences RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.14 Canopy Biosciences
- 13.14.1 Canopy Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Canopy Biosciences RNA-Seq Product Portfolio
- 13.14.3 Canopy Biosciences RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.15 Macrogen
- 13.15.1 Macrogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Macrogen RNA-Seq Product Portfolio
- 13.15.3 Macrogen RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.16 Hologic
- 13.16.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Hologic RNA-Seq Product Portfolio
- 13.16.3 Hologic RNA-Seq Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 14 Industry Chain Analysis
- 14.1 RNA-Seq Industry Chain Analysis
- 14.2 RNA-Seq Typical Downstream Customers
- 14.3 RNA-Seq Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
